Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage pass-through certificates from CROSS 2026-NQM1 Mortgage Trust, an RMBS transaction issued under the CROSS shelf, where APF II RESI O4B LLC and CrossCountry Capital are the co-sponsors. This $502.6 million transaction is collateralized by a pool of 958 residential mortgages, including a meaningful concentration of collateral that KBRA considers to be “non-prime” (69.6%), with fixed-rate mortgages (FRMs) and hy...

DENVER--(BUSINESS WIRE)--York announced the pricing of its upsized IPO of 18,500,000 shares of its common stock at a public offering price of $34 per share....

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following...

QUERÉTARO, Mexiko--(BUSINESS WIRE)--Canoga Perkins, ein weltweit führender Anbieter von privaten 5G-Netzwerkkonnektivitätslösungen, gibt die Eröffnung seines ersten internationalen privaten 5G-Kundenerlebniszentrums im BLOQUE in Querétaro, Mexiko, bekannt. Am 16. Januar 2026 stellte das Unternehmen das Produkt SyncMetra® 100 und eine End-to-End-Lösung für private 5G-Netzwerke auf der Veranstaltung „Experiencing SyncMetra®” vor, an der Regierungsvertreter, Vertreter der Stadt, Branchenführer, Te...

SELBYVILLE, Del.--(BUSINESS WIRE)--The Joshua M. Freeman Foundation Board of Directors announced today the planned transition of Executive Director Patti Grimes, who will step aside later this year following the appointment of her successor. Grimes has been a leader at the Foundation — and its signature venue, the Freeman Arts Pavilion — since its founding in 2007. Consistent with governance best practices and its commitment to long-term sustainability, the board has engaged the global executiv...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le traitement des maladies neurodégénératives de la rétine et du système nerveux central, annonce que son Assemblée Générale Extraordinaire, réunie ce jour à 15h00, a approuvé l’ensemble des résolutions soumises au vote des actionnaires, à l’exception de la 8ᵉ résol...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that its Extraordinary General Meeting held today at 3:00 p.m. approved all resolutions submitted to shareholders, with the exception of the 8th resolution relating to a reserved capital increase, which was...

SANTA ROSA, Calif.--(BUSINESS WIRE)--As California’s leading builder of solar-powered, ecologically responsible homes with multiple successful neighborhoods throughout Northern California, City Ventures has announced the official Grand Opening of Brittain Oaks—the builder’s seventh community in Santa Rosa alone. The highly anticipated neighborhood, which features brand-new, two-story townhomes, will unveil its decorated model homes to the public this weekend. “Santa Rosa is widely regarded as o...

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment in Coupang, Inc. (“Coupang” or the “Company”) (NYSE:CPNG), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until February 17, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff oversees...

NEW YORK--(BUSINESS WIRE)--Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or “the Company”), today announced it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, before the market opens. The Company will host an earnings conference call and public webcast at 10:00 AM Eastern Time the same day to discuss its financial results. All interested parties may participate in the conference call by dialing (866)-60...